Carolin Bender

1.1k total citations
10 papers, 257 citations indexed

About

Carolin Bender is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Carolin Bender has authored 10 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Carolin Bender's work include Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Carolin Bender is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (4 papers). Carolin Bender collaborates with scholars based in Germany, United States and China. Carolin Bender's co-authors include Jessica C. Hassel, Alexander Enk, Ralf Gutzmer, Julia K. Winkler, Alexandra Sevko, Antonia Dimitrakopoulou‐Strauss, Niels Halama, Huanhuan Jiang, Ivan Shevchenko and Viktor Umansky and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Dermatology and Cancer Immunology Immunotherapy.

In The Last Decade

Carolin Bender

10 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolin Bender Germany 9 172 117 79 30 21 10 257
Abdul Rafae United States 8 119 0.7× 24 0.2× 84 1.1× 20 0.7× 10 0.5× 34 256
Lishu Zhao China 10 109 0.6× 40 0.3× 74 0.9× 87 2.9× 16 0.8× 30 235
Matteo Pelosini Italy 11 141 0.8× 46 0.4× 61 0.8× 10 0.3× 25 369
Claudia Trojaniello Italy 12 178 1.0× 57 0.5× 110 1.4× 38 1.3× 2 0.1× 27 277
Jason T. Henry United States 12 140 0.8× 53 0.5× 78 1.0× 50 1.7× 5 0.2× 60 414
Garrett Desman United States 9 108 0.6× 52 0.4× 47 0.6× 24 0.8× 1 0.0× 30 245
Dong Geng United States 11 125 0.7× 128 1.1× 121 1.5× 24 0.8× 22 356
Saskia Herz Germany 5 143 0.8× 46 0.4× 9 0.1× 14 0.5× 14 0.7× 6 174
Anish Bhaswanth Chakka United States 9 47 0.3× 83 0.7× 87 1.1× 44 1.5× 8 0.4× 10 226
Melissa J. Rist Australia 8 56 0.3× 135 1.2× 74 0.9× 25 0.8× 9 0.4× 10 274

Countries citing papers authored by Carolin Bender

Since Specialization
Citations

This map shows the geographic impact of Carolin Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolin Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolin Bender more than expected).

Fields of papers citing papers by Carolin Bender

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolin Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolin Bender. The network helps show where Carolin Bender may publish in the future.

Co-authorship network of co-authors of Carolin Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Carolin Bender. A scholar is included among the top collaborators of Carolin Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolin Bender. Carolin Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Winkler, Julia K., et al.. (2018). Rituximab as a therapeutic option for patients with advanced melanoma. Cancer Immunology Immunotherapy. 67(6). 917–924. 23 indexed citations
2.
Hassel, Jessica C., Kristina Buder‐Bakhaya, Carolin Bender, et al.. (2017). Progression patterns under BRAF inhibitor treatment and treatment beyond progression in patients with metastatic melanoma. Cancer Medicine. 7(1). 95–104. 13 indexed citations
3.
Bender, Carolin, Jessica C. Hassel, Thomas Eigentler, et al.. (2017). Reinduction of PD1-inhibitor therapy: first experience in eight patients with metastatic melanoma. Melanoma Research. 27(4). 321–325. 42 indexed citations
4.
Bender, Carolin, Alexander Enk, Ralf Gutzmer, & Jessica C. Hassel. (2017). Anti‐PD‐1 antibodies in metastatic uveal melanoma: a treatment option?. Cancer Medicine. 6(7). 1581–1586. 23 indexed citations
5.
Hassel, Jessica C., Huanhuan Jiang, Carolin Bender, et al.. (2017). Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe). OncoImmunology. 6(9). e1326440–e1326440. 80 indexed citations
6.
Gutzmer, Ralf, Carolin Bender, Nina Lang, et al.. (2017). Safe Administration of An Anti-PD-1 Antibody to Kidney-transplant Patients: 2 Clinical Cases and Review of the Literature. Journal of Immunotherapy. 40(9). 341–344. 27 indexed citations
7.
Bender, Carolin, Jessica C. Hassel, & Alexander Enk. (2016). Immunotherapy of Melanoma. Oncology Research and Treatment. 39(6). 369–376. 14 indexed citations
8.
Winkler, Julia K., Carolin Bender, Clemens Kratochwil, Alexander Enk, & Jessica C. Hassel. (2016). PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma. British Journal of Dermatology. 176(1). 216–219. 16 indexed citations
9.
Heid, F., Carolin Bender, H. W. Gervais, et al.. (2015). Microbial contamination of anesthetic syringes in relation to different handling habits. American Journal of Infection Control. 44(3). e15–e17. 8 indexed citations
10.
Farah, A., Carolin Bender, R. Kruse, & Edward J. Cafruny. (1959). THE INFLUENCE OF ACIDOSIS AND ALKALOSIS ON MERCURIAL-INDUCED DIURESIS AND SULFHYDRYL CHANGES IN THE KIDNEY. Journal of Pharmacology and Experimental Therapeutics. 125(4). 309–315. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026